How do you decide?' Cancer patients die waiting for CAR-T therapy

“And people are dying. About 20% of all our patients together are actually dying before they can get CAR-T,” said Krina Patel, director of the myeloma cell therapy program at MD Anderson.

Loyola scientists working to make cancer treatment safer, cheaper: 'We shouldn't be sitting on our heels waiting for someone else' – Chicago Tribune

Why Choose CAR T-cell Therapy for Multiple Myeloma in Israel

BMS' Breyanzi sets new standards as the first CAR T-cell therapy for CLL and SLL

Mechanisms of resistance to CAR T cell therapy

Cancer Care, Durham, Raleigh, Cary, NC

What Happens if CAR T-Cell Therapy Fails?

CAR T Cell Therapy for The Treatment of Cancer - CancerConnect

Success Story: Canadian cancer survivor works with the NRC for broader access to CAR-T therapy

How CAR T-Cell Therapy 'Cured' 2 Cancer Patients

Multiple myeloma patients await MSAC verdict on CAR T-cell therapy to manage blood cancer - ABC News

FDA Approves Carvykti CAR T-Cell Therapy for Multiple Myeloma - NCI

Frontiers From bench to bedside: the history and progress of CAR T cell therapy

Taking Stock of CAR T-Cell Therapy

CAR-T therapies are manufactured for each individual patient